Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-07 1:45 pm Sale |
2023-12-31 | 13G | DA32 Life Science Tech Acquisition Corp. DALS |
Saba Capital Management, L.P. | 0 0.000% |
-1,258,277 (Position Closed) |
Filing History |
| 2023-09-11 4:36 pm Sale |
2023-08-31 | 13G | DA32 Life Science Tech Acquisition Corp. DALS |
First Trust Alternative Opportunities Fund | 0 0.000% |
-2,355,502 (Position Closed) |
Filing History |
| 2023-08-08 10:29 am Sale |
2023-07-31 | 13G | DA32 Life Science Tech Acquisition Corp. DALS |
BLACKROCK INC BLK |
0 0.000% |
-1,500,000 (Position Closed) |
Filing History |
| 2023-08-04 2:08 pm Sale |
2023-07-28 | 13D | DA32 Life Science Tech Acquisition Corp. DALS |
ARCH Venture Fund XI L.P. | 5,145,000 90.500% |
-1,600,000 (-23.72%) |
Filing History |
| 2023-08-02 4:10 pm Sale |
2023-07-28 | 13D | DA32 Life Science Tech Acquisition Corp. DALS |
Section 32 Fund 3 LP | 5,315,000 94.100% |
-800,000 (-13.08%) |
Filing History |
| 2023-08-01 5:22 pm Sale |
2023-07-28 | 13D | DA32 Life Science Tech Acquisition Corp. DALS |
DEERFIELD MANAGEMENT CO | 5,145,000 91.060% |
-1,600,000 (-23.72%) |
Filing History |
| 2023-08-01 4:15 pm Unchanged |
2023-07-28 | 13D | DA32 Life Science Tech Acquisition Corp. DALS |
DA32 Sponsor LLC | 5,115,000 90.500% |
0 (Unchanged) |
Filing History |
| 2023-05-15 5:01 pm Sale |
2023-05-15 | 13G | DA32 Life Science Tech Acquisition Corp. DALS |
RA Capital Management, L.P. | 0 0.000% |
-1,500,000 (Position Closed) |
Filing History |
| 2023-04-10 4:16 pm Purchase |
2023-03-31 | 13G | DA32 Life Science Tech Acquisition Corp. DALS |
First Trust Alternative Opportunities Fund | 2,355,502 11.410% |
2,355,502 (New Position) |
Filing History |
| 2023-02-14 06:49 am Purchase |
2022-12-31 | 13G | DA32 Life Science Tech Acquisition Corp. DALS |
Saba Capital Management, L.P. | 1,258,277 6.100% |
138,000 (+12.32%) |
Filing History |
| 2023-02-06 2:33 pm Sale |
2022-12-30 | 13G | DA32 Life Science Tech Acquisition Corp. DALS |
Wellington Management Portfolios (Dublin) Public Ltd Co | 0 0.000% |
-1,479,148 (Position Closed) |
Filing History |
| 2023-02-06 10:22 am Sale |
2022-12-31 | 13G | DA32 Life Science Tech Acquisition Corp. DALS |
Victory Capital Management, Inc. | 0 0.000% |
-1,126,959 (Position Closed) |
Filing History |
| 2023-01-31 1:58 pm Sale |
2022-12-31 | 13G | DA32 Life Science Tech Acquisition Corp. DALS |
BLACKROCK INC BLK |
1,500,000 7.300% |
-1,060 (-0.07%) |
Filing History |
| 2022-02-10 07:48 am Sale |
2022-01-31 | 13G | DA32 Life Science Tech Acquisition Corp. DALS |
WELLINGTON MANAGEMENT CO LLP | 0 0.000% |
-2,865,991 (Position Closed) |
Filing History |
| 2022-02-07 3:34 pm Purchase |
2022-01-28 | 13G | DA32 Life Science Tech Acquisition Corp. DALS |
Saba Capital Management, L.P. | 1,120,277 5.400% |
1,120,277 (New Position) |
Filing History |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | DA32 Life Science Tech Acquisition Corp. DALS |
BLACKROCK INC BLK |
1,501,060 7.300% |
1,501,060 (New Position) |
Filing History |
| 2022-02-04 09:15 am Sale |
2021-12-31 | 13G | DA32 Life Science Tech Acquisition Corp. DALS |
WELLINGTON MANAGEMENT CO LLP | 2,865,991 11.170% |
-242,546 (-7.80%) |
Filing History |
| 2022-02-04 07:59 am Sale |
2021-12-31 | 13G | DA32 Life Science Tech Acquisition Corp. DALS |
Wellington Management Portfolios (Dublin) Public Ltd Co | 1,479,148 5.770% |
-105,016 (-6.63%) |
Filing History |
| 2022-02-02 2:47 pm Purchase |
2021-12-31 | 13G | DA32 Life Science Tech Acquisition Corp. DALS |
Victory Capital Management, Inc. | 1,126,959 5.460% |
1,126,959 (New Position) |
Filing History |
| 2021-08-10 07:57 am Purchase |
2021-07-30 | 13G | DA32 Life Science Tech Acquisition Corp. DALS |
WELLINGTON MANAGEMENT CO LLP | 3,108,537 12.120% |
3,108,537 (New Position) |
Filing History |